Meningiomas in children and adolescents

Theodore Zwerdling, Judith Dothage

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

Purpose: To review the diagnosis, treatment, and long-term outcome eof children and adolescents with meningiomas diagnosed by a single institution and compare these findings with other published data. Patients and Methods: A 25-year retrospective analysis of 18 patients with meningioma diagnosed at Children's Hospital Medical Center, Cincinnati, Ohio was performed. A literature review of published reports was undertaken to compare evaluation, treatment, and outcome for similar patients. Results: Patients ranged from ages 19 months to 17 years at diagnosis. The most common symptoms were headache (5) and seizures (5), although most patients had multiple symptoms. The brain was the primary location of tumor in 17 patients, with the remaining tumor located in the spine. Comorbid diagnoses were common, including developmental delay, balanced chromosomal translocation, type I diabetes mellitus, neurofibromatosis, Klinefelter syndrome, and seizures. Eleven patients had gross total resection performed. Four patients had malignant meningiomas. Two patients were treated with radiotherapy only, one had chemotherapy only, and two underwent both. Karyotype abnormalities most commonly involved chromosome 22, but other abnormalities were present. Sixteen patients remain alive and two patients, having had malignant tumors, are dead of disease. Long-term sequelae include seizures, diabetes insipidus, blindness, neuropsychologic abnormalities, and multiple surgical procedures. Only three patients are self-described as being without problems. Conclusions: Based on this study and a literature review, the roles of surgery, radiation, and chemotherapy remain unclear. Long-term outcome for patients with meningiomas, especially as it relates to cognitive function, is rarely reported. This group of patients has a high incidence of morbidity associated not only with treatment but also with preexisting diseases. These data indicate the need for a national cooperative group study to better understand the evaluation, treatment, and outcome for children and adolescents who are treated for meningiomas.

Original languageEnglish (US)
Pages (from-to)199-204
Number of pages6
JournalJournal of Pediatric Hematology/Oncology
Volume24
Issue number3
DOIs
StatePublished - 2002

Fingerprint

Meningioma
Seizures
Multiple Abnormalities
Klinefelter Syndrome
Drug Therapy
Chromosomes, Human, Pair 22
Neoplasms
Genetic Translocation
Diabetes Insipidus
Preexisting Condition Coverage
Neurofibromatoses
Blindness
Type 1 Diabetes Mellitus
Karyotype
Cognition
Headache
Spine
Radiotherapy

Keywords

  • Adolescents
  • Children
  • Meningiomas

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Oncology
  • Hematology

Cite this

Meningiomas in children and adolescents. / Zwerdling, Theodore; Dothage, Judith.

In: Journal of Pediatric Hematology/Oncology, Vol. 24, No. 3, 2002, p. 199-204.

Research output: Contribution to journalArticle

@article{16f116def2c84502a2197ba859281d2e,
title = "Meningiomas in children and adolescents",
abstract = "Purpose: To review the diagnosis, treatment, and long-term outcome eof children and adolescents with meningiomas diagnosed by a single institution and compare these findings with other published data. Patients and Methods: A 25-year retrospective analysis of 18 patients with meningioma diagnosed at Children's Hospital Medical Center, Cincinnati, Ohio was performed. A literature review of published reports was undertaken to compare evaluation, treatment, and outcome for similar patients. Results: Patients ranged from ages 19 months to 17 years at diagnosis. The most common symptoms were headache (5) and seizures (5), although most patients had multiple symptoms. The brain was the primary location of tumor in 17 patients, with the remaining tumor located in the spine. Comorbid diagnoses were common, including developmental delay, balanced chromosomal translocation, type I diabetes mellitus, neurofibromatosis, Klinefelter syndrome, and seizures. Eleven patients had gross total resection performed. Four patients had malignant meningiomas. Two patients were treated with radiotherapy only, one had chemotherapy only, and two underwent both. Karyotype abnormalities most commonly involved chromosome 22, but other abnormalities were present. Sixteen patients remain alive and two patients, having had malignant tumors, are dead of disease. Long-term sequelae include seizures, diabetes insipidus, blindness, neuropsychologic abnormalities, and multiple surgical procedures. Only three patients are self-described as being without problems. Conclusions: Based on this study and a literature review, the roles of surgery, radiation, and chemotherapy remain unclear. Long-term outcome for patients with meningiomas, especially as it relates to cognitive function, is rarely reported. This group of patients has a high incidence of morbidity associated not only with treatment but also with preexisting diseases. These data indicate the need for a national cooperative group study to better understand the evaluation, treatment, and outcome for children and adolescents who are treated for meningiomas.",
keywords = "Adolescents, Children, Meningiomas",
author = "Theodore Zwerdling and Judith Dothage",
year = "2002",
doi = "10.1097/00043426-200203000-00008",
language = "English (US)",
volume = "24",
pages = "199--204",
journal = "Journal of Pediatric Hematology/Oncology",
issn = "1077-4114",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Meningiomas in children and adolescents

AU - Zwerdling, Theodore

AU - Dothage, Judith

PY - 2002

Y1 - 2002

N2 - Purpose: To review the diagnosis, treatment, and long-term outcome eof children and adolescents with meningiomas diagnosed by a single institution and compare these findings with other published data. Patients and Methods: A 25-year retrospective analysis of 18 patients with meningioma diagnosed at Children's Hospital Medical Center, Cincinnati, Ohio was performed. A literature review of published reports was undertaken to compare evaluation, treatment, and outcome for similar patients. Results: Patients ranged from ages 19 months to 17 years at diagnosis. The most common symptoms were headache (5) and seizures (5), although most patients had multiple symptoms. The brain was the primary location of tumor in 17 patients, with the remaining tumor located in the spine. Comorbid diagnoses were common, including developmental delay, balanced chromosomal translocation, type I diabetes mellitus, neurofibromatosis, Klinefelter syndrome, and seizures. Eleven patients had gross total resection performed. Four patients had malignant meningiomas. Two patients were treated with radiotherapy only, one had chemotherapy only, and two underwent both. Karyotype abnormalities most commonly involved chromosome 22, but other abnormalities were present. Sixteen patients remain alive and two patients, having had malignant tumors, are dead of disease. Long-term sequelae include seizures, diabetes insipidus, blindness, neuropsychologic abnormalities, and multiple surgical procedures. Only three patients are self-described as being without problems. Conclusions: Based on this study and a literature review, the roles of surgery, radiation, and chemotherapy remain unclear. Long-term outcome for patients with meningiomas, especially as it relates to cognitive function, is rarely reported. This group of patients has a high incidence of morbidity associated not only with treatment but also with preexisting diseases. These data indicate the need for a national cooperative group study to better understand the evaluation, treatment, and outcome for children and adolescents who are treated for meningiomas.

AB - Purpose: To review the diagnosis, treatment, and long-term outcome eof children and adolescents with meningiomas diagnosed by a single institution and compare these findings with other published data. Patients and Methods: A 25-year retrospective analysis of 18 patients with meningioma diagnosed at Children's Hospital Medical Center, Cincinnati, Ohio was performed. A literature review of published reports was undertaken to compare evaluation, treatment, and outcome for similar patients. Results: Patients ranged from ages 19 months to 17 years at diagnosis. The most common symptoms were headache (5) and seizures (5), although most patients had multiple symptoms. The brain was the primary location of tumor in 17 patients, with the remaining tumor located in the spine. Comorbid diagnoses were common, including developmental delay, balanced chromosomal translocation, type I diabetes mellitus, neurofibromatosis, Klinefelter syndrome, and seizures. Eleven patients had gross total resection performed. Four patients had malignant meningiomas. Two patients were treated with radiotherapy only, one had chemotherapy only, and two underwent both. Karyotype abnormalities most commonly involved chromosome 22, but other abnormalities were present. Sixteen patients remain alive and two patients, having had malignant tumors, are dead of disease. Long-term sequelae include seizures, diabetes insipidus, blindness, neuropsychologic abnormalities, and multiple surgical procedures. Only three patients are self-described as being without problems. Conclusions: Based on this study and a literature review, the roles of surgery, radiation, and chemotherapy remain unclear. Long-term outcome for patients with meningiomas, especially as it relates to cognitive function, is rarely reported. This group of patients has a high incidence of morbidity associated not only with treatment but also with preexisting diseases. These data indicate the need for a national cooperative group study to better understand the evaluation, treatment, and outcome for children and adolescents who are treated for meningiomas.

KW - Adolescents

KW - Children

KW - Meningiomas

UR - http://www.scopus.com/inward/record.url?scp=0036221023&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036221023&partnerID=8YFLogxK

U2 - 10.1097/00043426-200203000-00008

DO - 10.1097/00043426-200203000-00008

M3 - Article

C2 - 11990306

AN - SCOPUS:0036221023

VL - 24

SP - 199

EP - 204

JO - Journal of Pediatric Hematology/Oncology

JF - Journal of Pediatric Hematology/Oncology

SN - 1077-4114

IS - 3

ER -